37 results on '"Coens, C."'
Search Results
2. 1021 Effect of 6 months of androgen deprivation therapy on progression-free survival and quality of life in localized T1b-cT2aN0M0 prostate cancer
3. Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patients.
4. Health-related quality of life in EORTC clinical trials -- 30 years of progress from methodological developments to making a real impact on oncology practice.
5. Satistical methodology for personalized medicine: new developments at EORTC headquarters since the turn of the 21st century.
6. Statistical methodology for personalized medicine: New developments at EORTC Headquarters since the turn of the 21st Century.
7. Determinants of patient satisfaction in oncology settings from European and Asian countries: Preliminary results based on the EORTC IN-PATSAT32 questionnaire
8. 3035 POSTER Effect of Completion-time Windows in the Analysis of Health-Related Quality of Life (HRQOL) Outcomes
9. 3005 POSTER DISCUSSION Is There Any Added Value in the Pooled Analysis of Over 120 Large Scale Phase III Randomized Clinical Trials in Health Related Quality of Life?
10. 4218 Determining the minimal clinically important difference for health related quality of life scores from the EORTC QLQ-C30 in lung cancer patients: an analysis of pooled data.
11. 4165 An evaluation of the association between age and health related quality of life and symptoms in cancer patients – a pooled analysis of closed EORTC Randomized Controlled Trials.
12. 3001 Factor analysis of the Health-Related Quality of Life indicators of the QLQ-C30 in 6798 cancer patients.
13. LBA1 A randomized multicenter open label phase III trial comparing enzalutamide vs a combination of Radium-223 (Ra223) and enzalutamide in asymptomatic or mildly symptomatic patients with bone metastatic castration-resistant prostate cancer (mCRPC): First results of EORTC-GUCG 1333/PEACE-3
14. Understanding the problem of inadequately staging early ovarian cancer.
15. Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865)
16. Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?
17. Health-related quality of life in patients with glioblastoma: a randomised controlled trial.
18. PCN457 THE SISAQOL INITIATIVE: ESTABLISHING INTERNATIONAL STANDARDS AND RECOMMENDATIONS FOR THE ANALYSIS OF PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE DATA IN ONCOLOGY RANDOMIZED CLINICAL TRIALS.
19. LBA44 Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: Long-term quality of life analysis results of the EORTC 1325-MG/Keynote-054 double-blinded phase III trial.
20. Systemic review: Radiation therapy alone in medical non-operable endometrial carcinoma.
21. 1526TiP TOLERANCE: An EORTC STBSG-QLG-ETF 3-arm randomized study on health-related quality of life of elderly patients with advanced soft tissue sarcoma undergoing doxorubicin alone three weekly or doxorubicin weekly or cyclophosphamide plus predniso(lo)ne treatment
22. CN3 Validation Study Of The Baseline Quality Of Life As A Prognostic Indicator Of SURVIVAL: A Pooled Analysis Of Individual Patient Data From NCIC Clinical Trials
23. Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients.
24. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
25. Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer—Gynaecological Cancer ...
26. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)
27. Randomised trial of drains versus no drains following radical hysterectomy and pelvic lymph node dissection: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG) study in 234 patients
28. An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32)
29. Health related quality of life outcomes in cancer clinical trials
30. Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial.
31. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer
32. Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer
33. Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)
34. 1540PDHealth-related quality of life in randomized controlled trials: A systematic review of prognostic significance.
35. 3034 POSTER Health-Related Quality of Life in Small-Cell Lung Cancer: a Systematic Review on Methodological Issues in Randomized Controlled Trials
36. Corrigendum to “Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)” [European Journal of Cancer, 44 (2008) 808–818]
37. P-393 Treatment related quality of life findings in patients withmalignant pleural mesothelioma: An international randomized Phase III study of cisplatin with or without raltitrexed
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.